UHRF1 confers radioresistance to human breast cancer cells

Int J Radiat Biol. 2011 Mar;87(3):263-73. doi: 10.3109/09553002.2011.530335. Epub 2010 Nov 10.

Abstract

Purpose: To investigate the effect of ubiquitin-like with plant homeodomain (PHD) and ring finger domains 1 (UHRF1) overexpression on radiosensitivity to X-rays in human breast cancer MDA-MB-231 cells.

Materials and methods: Cell survival was determined by colony formation assay; cell cycle distribution was measured by flow cytometry; apoptosis was evaluated by DNA fragmentation assay and Annexin V apoptosis detection kit; protein expression was analysed by Western blot assay; chromosome aberrations (centric rings and dicentrics) were assayed by conventional chromosome analysis.

Results: A significant decrease of radiosensitivity to X-rays was observed in MDA-MB-231 cells transfected with a full-length of human UHRF1 cDNA (MDA-MB-231/UHRF1) compared to the control cells (MDA-MB-231/parental and MDA-MB-231/pcDNA3 [mammalian expression vector]), and the similar results were observed in MDA-MB-468 cells. In contrast, a decreased expression of UHRF1 by a specific UHRF1-small interfering RNA (siRNA) significantly enhanced cell radiosensitivity. The UHRF1-mediated radioresistance was correlated with a G2(Ra)/M arrest, a decreased induction of apoptosis, a down-regulation of the pro-apoptotic protein anti-B cell lymphoma/leukemia 2 (bcl-2) associated X protein (Bax) and a up-regulation of the DNA damage repair proteins Lupus Ku autoantigen protein p70 (Ku-70) and Lupus Ku autoantigen protein p80 (Ku-80). Furthermore, chromosomal aberrations (centric rings and dicentrics) by X-rays were less in MDA-MB-231/UHRF1 than in MDA-MB-231/parental and MDA-MB-231/pcDNA3 control cells.

Conclusions: These results suggested that UHRF1 may be a new target in the radiotherapy of breast cancer via affecting apoptosis and DNA damage repair.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Annexin A5 / pharmacology
  • Antigens, Nuclear / pharmacology
  • Apoptosis
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / radiotherapy*
  • CCAAT-Enhancer-Binding Proteins / metabolism*
  • Cell Line, Tumor
  • DNA Fragmentation
  • DNA-Binding Proteins / pharmacology
  • Drug Resistance, Neoplasm*
  • Flow Cytometry / methods
  • Humans
  • Ku Autoantigen
  • Mice
  • Nuclear Proteins / metabolism*
  • Radiation Tolerance
  • Ubiquitin-Protein Ligases
  • bcl-2-Associated X Protein / metabolism

Substances

  • Annexin A5
  • Antigens, Nuclear
  • BAX protein, human
  • CCAAT-Enhancer-Binding Proteins
  • DNA-Binding Proteins
  • Nuclear Proteins
  • bcl-2-Associated X Protein
  • UHRF1 protein, human
  • Ubiquitin-Protein Ligases
  • Uhrf1 protein, mouse
  • Xrcc6 protein, human
  • Xrcc6 protein, mouse
  • Ku Autoantigen